Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Long-Read Sequencing Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Long-Read Sequencing Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Medical Devices & Consumables
Published Date: 2026-03-26
Pages: 172 Pages
Report ld: 6321839
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Long-Read Sequencing Market Size(US$)
CAGR 2026-2032
21.6%
Market Size,2032
USD 3,283
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 1,015 million
Market Forecast in 2032(Value)
US$ 3,283 million
CAGR
21.6%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Long-Read Sequencing market is projected to grow from US$ 850 million in 2025 to US$ 3283 million by 2032, at a CAGR of 21.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Long-read sequencing is a form of next-generation sequencing (NGS) that has technical advantages over short-read sequencing for the detection of specific types of genetic variation. It can sequence long strands of DNA or RNA in one go, without breaking it up into smaller fragments.
From a downstream perspective, Research Institutes accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Long-Read Sequencing leading players (including Oxford Nanopore, Agilent Technologies, Thermo Fisher Scientific, QIAGEN, PacBio, Illumina, Takara Bio, 10X Genomics, Danaher, Azenta US, etc.), dominate supply; the top five capture approximately % of global revenue, with Oxford Nanopore leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Long-Read Sequencing market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Oxford Nanopore
- Agilent Technologies
- Thermo Fisher Scientific
- QIAGEN
- PacBio
- Illumina
- Takara Bio
- 10X Genomics
- Danaher
- Azenta US
- Revvity
- New England Biolabs
- BaseClear
- Element Biosciences
- CD Genomics
- Sage Sciences
- EdenRoc Sciences
- BGI Group
- Novogene
- Grandomics
- Wuhan Beina Technology
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Nanopore Sequencing
- Single-molecule Real-time Sequencing
- Synthetic Long-read Sequencing
Segment by Application
- Research Institutes
- Hospitals
- Pharmaceutical
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Long-Read Sequencing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Long-Read Sequencing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Long-Read Sequencing Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Nanopore Sequencing
1.2.3 Single-molecule Real-time Sequencing
1.2.4 Synthetic Long-read Sequencing
1.3 Market Segmentation by Application
1.3.1 Global Long-Read Sequencing Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Research Institutes
1.3.3 Hospitals
1.3.4 Pharmaceutical
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Long-Read Sequencing Revenue Estimates and Forecasts (2021-2032)
2.2 Global Long-Read Sequencing Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global Long-Read Sequencing Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Long-Read Sequencing Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Nanopore Sequencing: Market Share by Key Players
3.3.2 Single-molecule Real-time Sequencing: Market Share by Key Players
3.3.3 Synthetic Long-read Sequencing: Market Share by Key Players
3.4 Global Long-Read Sequencing Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global Long-Read Sequencing Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Long-Read Sequencing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Long-Read Sequencing Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Long-Read Sequencing Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Long-Read Sequencing Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Long-Read Sequencing Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Long-Read Sequencing Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Long-Read Sequencing Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Long-Read Sequencing Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Long-Read Sequencing Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Long-Read Sequencing Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Long-Read Sequencing Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Oxford Nanopore
11.1.1 Oxford Nanopore Corporation Information
11.1.2 Oxford Nanopore Business Overview
11.1.3 Oxford Nanopore Long-Read Sequencing Product Features and Attributes
11.1.4 Oxford Nanopore Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.1.5 Oxford Nanopore Long-Read Sequencing Revenue by Product in 2025
11.1.6 Oxford Nanopore Long-Read Sequencing Revenue by Application in 2025
11.1.7 Oxford Nanopore Long-Read Sequencing Revenue by Geographic Area in 2025
11.1.8 Oxford Nanopore Long-Read Sequencing SWOT Analysis
11.1.9 Oxford Nanopore Recent Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Corporation Information
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Long-Read Sequencing Product Features and Attributes
11.2.4 Agilent Technologies Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.2.5 Agilent Technologies Long-Read Sequencing Revenue by Product in 2025
11.2.6 Agilent Technologies Long-Read Sequencing Revenue by Application in 2025
11.2.7 Agilent Technologies Long-Read Sequencing Revenue by Geographic Area in 2025
11.2.8 Agilent Technologies Long-Read Sequencing SWOT Analysis
11.2.9 Agilent Technologies Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Corporation Information
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Long-Read Sequencing Product Features and Attributes
11.3.4 Thermo Fisher Scientific Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.3.5 Thermo Fisher Scientific Long-Read Sequencing Revenue by Product in 2025
11.3.6 Thermo Fisher Scientific Long-Read Sequencing Revenue by Application in 2025
11.3.7 Thermo Fisher Scientific Long-Read Sequencing Revenue by Geographic Area in 2025
11.3.8 Thermo Fisher Scientific Long-Read Sequencing SWOT Analysis
11.3.9 Thermo Fisher Scientific Recent Developments
11.4 QIAGEN
11.4.1 QIAGEN Corporation Information
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Long-Read Sequencing Product Features and Attributes
11.4.4 QIAGEN Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.4.5 QIAGEN Long-Read Sequencing Revenue by Product in 2025
11.4.6 QIAGEN Long-Read Sequencing Revenue by Application in 2025
11.4.7 QIAGEN Long-Read Sequencing Revenue by Geographic Area in 2025
11.4.8 QIAGEN Long-Read Sequencing SWOT Analysis
11.4.9 QIAGEN Recent Developments
11.5 PacBio
11.5.1 PacBio Corporation Information
11.5.2 PacBio Business Overview
11.5.3 PacBio Long-Read Sequencing Product Features and Attributes
11.5.4 PacBio Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.5.5 PacBio Long-Read Sequencing Revenue by Product in 2025
11.5.6 PacBio Long-Read Sequencing Revenue by Application in 2025
11.5.7 PacBio Long-Read Sequencing Revenue by Geographic Area in 2025
11.5.8 PacBio Long-Read Sequencing SWOT Analysis
11.5.9 PacBio Recent Developments
11.6 Illumina
11.6.1 Illumina Corporation Information
11.6.2 Illumina Business Overview
11.6.3 Illumina Long-Read Sequencing Product Features and Attributes
11.6.4 Illumina Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.6.5 Illumina Recent Developments
11.7 Takara Bio
11.7.1 Takara Bio Corporation Information
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio Long-Read Sequencing Product Features and Attributes
11.7.4 Takara Bio Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.7.5 Takara Bio Recent Developments
11.8 10X Genomics
11.8.1 10X Genomics Corporation Information
11.8.2 10X Genomics Business Overview
11.8.3 10X Genomics Long-Read Sequencing Product Features and Attributes
11.8.4 10X Genomics Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.8.5 10X Genomics Recent Developments
11.9 Danaher
11.9.1 Danaher Corporation Information
11.9.2 Danaher Business Overview
11.9.3 Danaher Long-Read Sequencing Product Features and Attributes
11.9.4 Danaher Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.9.5 Danaher Recent Developments
11.10 Azenta US
11.10.1 Azenta US Corporation Information
11.10.2 Azenta US Business Overview
11.10.3 Azenta US Long-Read Sequencing Product Features and Attributes
11.10.4 Azenta US Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 Revvity
11.11.1 Revvity Corporation Information
11.11.2 Revvity Business Overview
11.11.3 Revvity Long-Read Sequencing Product Features and Attributes
11.11.4 Revvity Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.11.5 Revvity Recent Developments
11.12 New England Biolabs
11.12.1 New England Biolabs Corporation Information
11.12.2 New England Biolabs Business Overview
11.12.3 New England Biolabs Long-Read Sequencing Product Features and Attributes
11.12.4 New England Biolabs Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.12.5 New England Biolabs Recent Developments
11.13 BaseClear
11.13.1 BaseClear Corporation Information
11.13.2 BaseClear Business Overview
11.13.3 BaseClear Long-Read Sequencing Product Features and Attributes
11.13.4 BaseClear Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.13.5 BaseClear Recent Developments
11.14 Element Biosciences
11.14.1 Element Biosciences Corporation Information
11.14.2 Element Biosciences Business Overview
11.14.3 Element Biosciences Long-Read Sequencing Product Features and Attributes
11.14.4 Element Biosciences Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.14.5 Element Biosciences Recent Developments
11.15 CD Genomics
11.15.1 CD Genomics Corporation Information
11.15.2 CD Genomics Business Overview
11.15.3 CD Genomics Long-Read Sequencing Product Features and Attributes
11.15.4 CD Genomics Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.15.5 CD Genomics Recent Developments
11.16 Sage Sciences
11.16.1 Sage Sciences Corporation Information
11.16.2 Sage Sciences Business Overview
11.16.3 Sage Sciences Long-Read Sequencing Product Features and Attributes
11.16.4 Sage Sciences Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.16.5 Sage Sciences Recent Developments
11.17 EdenRoc Sciences
11.17.1 EdenRoc Sciences Corporation Information
11.17.2 EdenRoc Sciences Business Overview
11.17.3 EdenRoc Sciences Long-Read Sequencing Product Features and Attributes
11.17.4 EdenRoc Sciences Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.17.5 EdenRoc Sciences Recent Developments
11.18 BGI Group
11.18.1 BGI Group Corporation Information
11.18.2 BGI Group Business Overview
11.18.3 BGI Group Long-Read Sequencing Product Features and Attributes
11.18.4 BGI Group Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.18.5 BGI Group Recent Developments
11.19 Novogene
11.19.1 Novogene Corporation Information
11.19.2 Novogene Business Overview
11.19.3 Novogene Long-Read Sequencing Product Features and Attributes
11.19.4 Novogene Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.19.5 Novogene Recent Developments
11.20 Grandomics
11.20.1 Grandomics Corporation Information
11.20.2 Grandomics Business Overview
11.20.3 Grandomics Long-Read Sequencing Product Features and Attributes
11.20.4 Grandomics Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.20.5 Grandomics Recent Developments
11.21 Wuhan Beina Technology
11.21.1 Wuhan Beina Technology Corporation Information
11.21.2 Wuhan Beina Technology Business Overview
11.21.3 Wuhan Beina Technology Long-Read Sequencing Product Features and Attributes
11.21.4 Wuhan Beina Technology Long-Read Sequencing Revenue and Gross Margin (2021-2026)
11.21.5 Wuhan Beina Technology Recent Developments
12 Long-Read Sequencing Value Chain and Ecosystem Analysis
12.1 Long-Read Sequencing Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Long-Read Sequencing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Long-Read Sequencing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Long-Read Sequencing Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Long-Read Sequencing Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Long-Read Sequencing Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Long-Read Sequencing Revenue by Region (US$ Million), 2021-2026
Table 5. Global Long-Read Sequencing Revenue by Region (US$ Million), 2027-2032
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 7. Global Long-Read Sequencing Revenue by Players (US$ Million), 2021-2026
Table 8. Global Long-Read Sequencing Revenue-Based Market Share by Players (2021-2026)
Table 9. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 10. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Long-Read Sequencing Revenue, 2025
Table 11. Global Long-Read Sequencing Average Gross Margin (%) by Player (2021 vs 2025)
Table 12. Global Long-Read Sequencing Companies Headquarters
Table 13. Global Long-Read Sequencing Market Concentration Ratio (CR5)
Table 14. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Long-Read Sequencing Revenue by Type (US$ Million), 2021-2026
Table 17. Global Long-Read Sequencing Revenue by Type (US$ Million), 2027-2032
Table 18. Key Product Attributes and Differentiation
Table 19. Global Long-Read Sequencing Revenue by Application (US$ Million), 2021-2026
Table 20. Global Long-Read Sequencing Revenue by Application (US$ Million), 2027-2032
Table 21. Long-Read Sequencing High-Growth Sectors Demand CAGR (2026-2032)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Long-Read Sequencing Growth Accelerators and Market Barriers
Table 25. North America Long-Read Sequencing Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 26. Europe Long-Read Sequencing Growth Accelerators and Market Barriers
Table 27. Europe Long-Read Sequencing Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. Asia-Pacific Long-Read Sequencing Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Long-Read Sequencing Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 30. Central and South America Long-Read Sequencing Investment Opportunities and Key Challenges
Table 31. Central and South America Long-Read Sequencing Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Middle East and Africa Long-Read Sequencing Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Long-Read Sequencing Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 34. Oxford Nanopore Corporation Information
Table 35. Oxford Nanopore Description and Major Businesses
Table 36. Oxford Nanopore Product Features and Attributes
Table 37. Oxford Nanopore Revenue (US$ Million) and Gross Margin (2021-2026)
Table 38. Oxford Nanopore Revenue Proportion by Product in 2025
Table 39. Oxford Nanopore Revenue Proportion by Application in 2025
Table 40. Oxford Nanopore Revenue Proportion by Geographic Area in 2025
Table 41. Oxford Nanopore Long-Read Sequencing SWOT Analysis
Table 42. Oxford Nanopore Recent Developments
Table 43. Agilent Technologies Corporation Information
Table 44. Agilent Technologies Description and Major Businesses
Table 45. Agilent Technologies Product Features and Attributes
Table 46. Agilent Technologies Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. Agilent Technologies Revenue Proportion by Product in 2025
Table 48. Agilent Technologies Revenue Proportion by Application in 2025
Table 49. Agilent Technologies Revenue Proportion by Geographic Area in 2025
Table 50. Agilent Technologies Long-Read Sequencing SWOT Analysis
Table 51. Agilent Technologies Recent Developments
Table 52. Thermo Fisher Scientific Corporation Information
Table 53. Thermo Fisher Scientific Description and Major Businesses
Table 54. Thermo Fisher Scientific Product Features and Attributes
Table 55. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. Thermo Fisher Scientific Revenue Proportion by Product in 2025
Table 57. Thermo Fisher Scientific Revenue Proportion by Application in 2025
Table 58. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2025
Table 59. Thermo Fisher Scientific Long-Read Sequencing SWOT Analysis
Table 60. Thermo Fisher Scientific Recent Developments
Table 61. QIAGEN Corporation Information
Table 62. QIAGEN Description and Major Businesses
Table 63. QIAGEN Product Features and Attributes
Table 64. QIAGEN Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. QIAGEN Revenue Proportion by Product in 2025
Table 66. QIAGEN Revenue Proportion by Application in 2025
Table 67. QIAGEN Revenue Proportion by Geographic Area in 2025
Table 68. QIAGEN Long-Read Sequencing SWOT Analysis
Table 69. QIAGEN Recent Developments
Table 70. PacBio Corporation Information
Table 71. PacBio Description and Major Businesses
Table 72. PacBio Product Features and Attributes
Table 73. PacBio Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. PacBio Revenue Proportion by Product in 2025
Table 75. PacBio Revenue Proportion by Application in 2025
Table 76. PacBio Revenue Proportion by Geographic Area in 2025
Table 77. PacBio Long-Read Sequencing SWOT Analysis
Table 78. PacBio Recent Developments
Table 79. Illumina Corporation Information
Table 80. Illumina Description and Major Businesses
Table 81. Illumina Product Features and Attributes
Table 82. Illumina Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Illumina Recent Developments
Table 84. Takara Bio Corporation Information
Table 85. Takara Bio Description and Major Businesses
Table 86. Takara Bio Product Features and Attributes
Table 87. Takara Bio Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. Takara Bio Recent Developments
Table 89. 10X Genomics Corporation Information
Table 90. 10X Genomics Description and Major Businesses
Table 91. 10X Genomics Product Features and Attributes
Table 92. 10X Genomics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. 10X Genomics Recent Developments
Table 94. Danaher Corporation Information
Table 95. Danaher Description and Major Businesses
Table 96. Danaher Product Features and Attributes
Table 97. Danaher Revenue (US$ Million) and Gross Margin (2021-2026)
Table 98. Danaher Recent Developments
Table 99. Azenta US Corporation Information
Table 100. Azenta US Description and Major Businesses
Table 101. Azenta US Product Features and Attributes
Table 102. Azenta US Revenue (US$ Million) and Gross Margin (2021-2026)
Table 103. Azenta US Recent Developments
Table 104. Revvity Corporation Information
Table 105. Revvity Description and Major Businesses
Table 106. Revvity Product Features and Attributes
Table 107. Revvity Revenue (US$ Million) and Gross Margin (2021-2026)
Table 108. Revvity Recent Developments
Table 109. New England Biolabs Corporation Information
Table 110. New England Biolabs Description and Major Businesses
Table 111. New England Biolabs Product Features and Attributes
Table 112. New England Biolabs Revenue (US$ Million) and Gross Margin (2021-2026)
Table 113. New England Biolabs Recent Developments
Table 114. BaseClear Corporation Information
Table 115. BaseClear Description and Major Businesses
Table 116. BaseClear Product Features and Attributes
Table 117. BaseClear Revenue (US$ Million) and Gross Margin (2021-2026)
Table 118. BaseClear Recent Developments
Table 119. Element Biosciences Corporation Information
Table 120. Element Biosciences Description and Major Businesses
Table 121. Element Biosciences Product Features and Attributes
Table 122. Element Biosciences Revenue (US$ Million) and Gross Margin (2021-2026)
Table 123. Element Biosciences Recent Developments
Table 124. CD Genomics Corporation Information
Table 125. CD Genomics Description and Major Businesses
Table 126. CD Genomics Product Features and Attributes
Table 127. CD Genomics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 128. CD Genomics Recent Developments
Table 129. Sage Sciences Corporation Information
Table 130. Sage Sciences Description and Major Businesses
Table 131. Sage Sciences Product Features and Attributes
Table 132. Sage Sciences Revenue (US$ Million) and Gross Margin (2021-2026)
Table 133. Sage Sciences Recent Developments
Table 134. EdenRoc Sciences Corporation Information
Table 135. EdenRoc Sciences Description and Major Businesses
Table 136. EdenRoc Sciences Product Features and Attributes
Table 137. EdenRoc Sciences Revenue (US$ Million) and Gross Margin (2021-2026)
Table 138. EdenRoc Sciences Recent Developments
Table 139. BGI Group Corporation Information
Table 140. BGI Group Description and Major Businesses
Table 141. BGI Group Product Features and Attributes
Table 142. BGI Group Revenue (US$ Million) and Gross Margin (2021-2026)
Table 143. BGI Group Recent Developments
Table 144. Novogene Corporation Information
Table 145. Novogene Description and Major Businesses
Table 146. Novogene Product Features and Attributes
Table 147. Novogene Revenue (US$ Million) and Gross Margin (2021-2026)
Table 148. Novogene Recent Developments
Table 149. Grandomics Corporation Information
Table 150. Grandomics Description and Major Businesses
Table 151. Grandomics Product Features and Attributes
Table 152. Grandomics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 153. Grandomics Recent Developments
Table 154. Wuhan Beina Technology Corporation Information
Table 155. Wuhan Beina Technology Description and Major Businesses
Table 156. Wuhan Beina Technology Product Features and Attributes
Table 157. Wuhan Beina Technology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 158. Wuhan Beina Technology Recent Developments
Table 159. Technologies, Platforms and Infrastructure
Table 160. Distributors List
Table 161. Market Trends and Market Evolution
Table 162. Market Drivers and Opportunities
Table 163. Market Challenges, Risks, and Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long-Read Sequencing Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Nanopore Sequencing Product Picture
Figure 3. Single-molecule Real-time Sequencing Product Picture
Figure 4. Synthetic Long-read Sequencing Product Picture
Figure 5. Global Long-Read Sequencing Market Size Growth Rate , 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Global Long-Read Sequencing Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 7. Research Institutes
Figure 8. Hospitals
Figure 9. Pharmaceutical
Figure 10. Others
Figure 11. Long-Read Sequencing Report Years Considered
Figure 12. Global Long-Read Sequencing Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 14. Global Long-Read Sequencing Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Global Long-Read Sequencing Revenue-Based Market Share by Region (2021-2032)
Figure 16. Global Long-Read Sequencing Revenue-Based Market Share Ranking (2025)
Figure 17. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 18. Nanopore Sequencing Revenue-Based Market Share by Player in 2025
Figure 19. Single-molecule Real-time Sequencing Revenue-Based Market Share by Player in 2025
Figure 20. Synthetic Long-read Sequencing Revenue-Based Market Share by Player in 2025
Figure 21. Global Long-Read Sequencing Revenue-Based Market Share by Type (2021-2032)
Figure 22. Global Long-Read Sequencing Revenue-Based Market Share by Application (2021-2032)
Figure 23. North America Long-Read Sequencing Revenue YoY (US$ Million), 2021-2032
Figure 24. North America Top 5 Players Long-Read Sequencing Revenue (US$ Million) in 2025
Figure 25. North America Long-Read Sequencing Revenue (US$ Million) by Application (2021-2032)
Figure 26. US Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 27. Canada Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 28. Mexico Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 29. Europe Long-Read Sequencing Revenue YoY (US$ Million), 2021-2032
Figure 30. Europe Top 5 Players Long-Read Sequencing Revenue (US$ Million) in 2025
Figure 31. Europe Long-Read Sequencing Revenue (US$ Million) by Application (2021-2032)
Figure 32. Germany Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 33. France Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 34. U.K. Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 35. Italy Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 36. Russia Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 37. Asia-Pacific Long-Read Sequencing Revenue YoY (US$ Million), 2021-2032
Figure 38. Asia-Pacific Top 8 Players Long-Read Sequencing Revenue (US$ Million) in 2025
Figure 39. Asia-Pacific Long-Read Sequencing Revenue (US$ Million) by Application (2021-2032)
Figure 40. Indonesia Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 41. Japan Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 42. South Korea Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 43. Australia Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 44. India Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 45. Indonesia Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 46. Vietnam Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 47. Malaysia Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 48. Philippines Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 49. Singapore Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 50. Central and South America Long-Read Sequencing Revenue YoY (US$ Million), 2021-2032
Figure 51. Central and South America Top 5 Players Long-Read Sequencing Revenue (US$ Million) in 2025
Figure 52. Central and South America Long-Read Sequencing Revenue (US$ Million) by Application (2021-2032)
Figure 53. Brazil Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 54. Argentina Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 55. Middle East and Africa Long-Read Sequencing Revenue YoY (US$ Million), 2021-2032
Figure 56. Middle East and Africa Top 5 Players Long-Read Sequencing Revenue (US$ Million) in 2025
Figure 57. Middle East and Africa Long-Read Sequencing Revenue (US$ Million) by Application (2021-2032)
Figure 58. GCC Countries Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 59. Israel Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 60. Egypt Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 61. South Africa Long-Read Sequencing Revenue (US$ Million), 2021-2032
Figure 62. Long-Read Sequencing Value Chain Mapping
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Long-Read Sequencing in 2026?
The global market size of Long-Read Sequencing in 2026 was 1015 Million USD.
Which region is expected to have the highest market share?
What was the global market size of Long-Read Sequencing in 2032?
Which companies rank high in the global Long-Read Sequencing market?
What is the annual compound growth rate of the global Long-Read Sequencing market size from 2026 to 2032?
Related Reports
Global Long-Read Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Long-Read Sequencing market size was US$ 850 million in 2025 and is forecast to reach a readjusted size of US$ 3283 million by 2032 with a CAGR of 21.6% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 120
USD 4250.00
(Single User License)
Global Long-Read Sequencing Market Research Report 2026
The global Long-Read Sequencing market was valued at US$ 850 million in 2025 and is anticipated to reach US$ 3283 million by 2032, at a CAGR of 21.6% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 152
USD 2900.00
(Single User License)
Long-Read Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Long-Read Sequencing was estimated to be worth US$ 850 million in 2025 and is projected to reach US$ 3283 million, growing at a CAGR of 21.6% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 157
USD 3950.00
(Single User License)
Global Long-Read Sequencing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Long-Read Sequencing market is projected to grow from US$ 712 million in 2024 to US$ 2749 million by 2031, at a CAGR of 21.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 162
USD 4900.00
(Single User License)
Global Long-Read Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Long-Read Sequencing market size was US$ 712 million in 2024 and is forecast to a readjusted size of US$ 2749 million by 2031 with a CAGR of 21.6% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 112
USD 4250.00
(Single User License)
Long-Read Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Long-Read Sequencing was estimated to be worth US$ 712 million in 2024 and is forecast to a readjusted size of US$ 2749 million by 2031 with a CAGR of 21.6% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 149
USD 3950.00
(Single User License)
Global Long-Read Sequencing Market Research Report 2025
The global market for Long-Read Sequencing was valued at US$ 712 million in the year 2024 and is projected to reach a revised size of US$ 2749 million by 2031, growing at a CAGR of 21.6% during the forecast period.
Published Date: 2025-03-10
Pages: 102
USD 2900.00
(Single User License)
Global and United States Long-Read Sequencing Market Report & Forecast 2024-2030
Long-read sequencing is a form of next-generation sequencing (NGS) that has technical advantages over short-read sequencing for the detection of specific types of genetic variation. It can sequence long strands of DNA or RNA in one go, without breaking it up into smaller fragments.
Published Date: 2024-08-14
Pages: 136
USD 4350.00
(Single User License)
Global Long-Read Sequencing Market Research Report 2024
Long-read sequencing is a form of next-generation sequencing (NGS) that has technical advantages over short-read sequencing for the detection of specific types of genetic variation. It can sequence long strands of DNA or RNA in one go, without breaking it up into smaller fragments.
Published Date: 2024-08-14
Pages: 107
USD 2900.00
(Single User License)
Global Long-Read Sequencing Market Insights, Forecast to 2030
Long-read sequencing is a form of next-generation sequencing (NGS) that has technical advantages over short-read sequencing for the detection of specific types of genetic variation. It can sequence long strands of DNA or RNA in one go, without breaking it up into smaller fragments.
Published Date: 2024-08-14
Pages: 175
USD 4900.00
(Single User License)
Global Long-Read Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Long-Read Sequencing market size was US$ 850 million in 2025 and is forecast to reach a readjusted size of US$ 3283 million by 2032 with a CAGR of 21.6% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 120
USD 4250.00 (Single User License)Global Long-Read Sequencing Market Research Report 2026
The global Long-Read Sequencing market was valued at US$ 850 million in 2025 and is anticipated to reach US$ 3283 million by 2032, at a CAGR of 21.6% from 2026 to 2032.
Published: 2026-01-09
Pages: 152
USD 2900.00 (Single User License)Long-Read Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Long-Read Sequencing was estimated to be worth US$ 850 million in 2025 and is projected to reach US$ 3283 million, growing at a CAGR of 21.6% from 2026 to 2032.
Published: 2026-01-09
Pages: 157
USD 3950.00 (Single User License)Global Long-Read Sequencing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Long-Read Sequencing market is projected to grow from US$ 712 million in 2024 to US$ 2749 million by 2031, at a CAGR of 21.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 162
USD 4900.00 (Single User License)Global Long-Read Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Long-Read Sequencing market size was US$ 712 million in 2024 and is forecast to a readjusted size of US$ 2749 million by 2031 with a CAGR of 21.6% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 112
USD 4250.00 (Single User License)Long-Read Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Long-Read Sequencing was estimated to be worth US$ 712 million in 2024 and is forecast to a readjusted size of US$ 2749 million by 2031 with a CAGR of 21.6% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 149
USD 3950.00 (Single User License)Global Long-Read Sequencing Market Research Report 2025
The global market for Long-Read Sequencing was valued at US$ 712 million in the year 2024 and is projected to reach a revised size of US$ 2749 million by 2031, growing at a CAGR of 21.6% during the forecast period.
Published: 2025-03-10
Pages: 102
USD 2900.00 (Single User License)Global and United States Long-Read Sequencing Market Report & Forecast 2024-2030
Long-read sequencing is a form of next-generation sequencing (NGS) that has technical advantages over short-read sequencing for the detection of specific types of genetic variation. It can sequence long strands of DNA or RNA in one go, without breaking it up into smaller fragments.
Published: 2024-08-14
Pages: 136
USD 4350.00 (Single User License)Global Long-Read Sequencing Market Research Report 2024
Long-read sequencing is a form of next-generation sequencing (NGS) that has technical advantages over short-read sequencing for the detection of specific types of genetic variation. It can sequence long strands of DNA or RNA in one go, without breaking it up into smaller fragments.
Published: 2024-08-14
Pages: 107
USD 2900.00 (Single User License)Global Long-Read Sequencing Market Insights, Forecast to 2030
Long-read sequencing is a form of next-generation sequencing (NGS) that has technical advantages over short-read sequencing for the detection of specific types of genetic variation. It can sequence long strands of DNA or RNA in one go, without breaking it up into smaller fragments.
Published: 2024-08-14
Pages: 175
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now